Provectus Biopharmaceuticals to Hold 2026 Annual Meeting of Stockholders at Perkins Place, Its Planned New Headquarters in Knoxville, Tennessee
View original at globenewswire.comProvectus Biopharmaceuticals to Hold 2026 Annual Meeting of Stockholders at Perkins Place, Its Planned New Headquarters in Knoxville, Tennessee Company Marks First Annual Meeting at Historic Perkins Place Office Building as It Prepares to Relocate Its Headquarters from First Horizon Plaza Tower KNOXVILLE, Tenn., April…
What we drew from this source
The claims Via News extracted from this document. We point to the source; we don't replace it.
The safety and efficacy of the agents and/or uses under investigation have not been established. There is no guarantee that the agents will receive health authority approval or become commercially available in any country for the uses being investigated or that such agents as products will achieve any particular revenue levels.
60% confidenceProvectus's proprietary synthetic small molecule Rose Bengal Sodium is a molecule being systematically recognized and developed across oncology, dermatology, ophthalmology, and beyond.
60% confidenceHolding our 2026 Annual Meeting of Stockholders at Perkins Place is the right setting for this moment. The building's history reflects values we recognize in ourselves: vision applied to overlooked assets, perseverance, and outcomes others considered improbable.
60% confidencePerkins Place was not a new building when PYA first claimed it. In both cases, the value was already there. The work was to see it, commit to it, and build. We are planning to do that again at Provectus.
60% confidencePerkins Place is evidence of our expanding vision for Provectus
60% confidenceProvectus's planned relocation will provide the Company a pathway to effectively manage costs as it grows and adds resources. Additional land and flexible zoning create optionality for future facility development, including the potential for dedicated research, operational, and/or logistics-adjacent space.
60% confidenceThe Company intends to relocate from its current offices at 800 S. Gay Street, Suite 1610 (First Horizon Plaza Tower) to Perkins Place in 2026
60% confidence